Bluewater Bio International, a leading provider of innovative water and wastewater treatment technologies, has announced that it has concluded an agreement with Norwegian based Biowater Technology to market each other’s advanced, high rate filtration and Moving Bed Bio Reactor processes.

The agreement, which was finalised on 1st February, covers BwB’s FilterClear™ and Biowater’s CFIC® products on a global, non-exclusive basis.

Bluewater Bio said the agreement would enable it to further broaden and enhance an expanding portfolio of innovative technologies, strengthen their market position and open up new territories and vertical sectors worldwide.

The agreement marks the culmination of an increasingly close relationship over the past 18 months, illustrated by the co-installation of BwB’s FilterClear™ and Biowater’s CMFF® technologies on a water reuse system for the Nirlon ‘green campus’, near Mumbai, India.

Biowater see Bluewater Bio’s FilterClear as complementary to their current MBBR -based offering - in particular its key differentiators of class leading throughput rate and solids retention, high dirt holding capacity and low volume of backwash waste. In addition, the small footprint, minimum civil works, quick on-site installation and minimal operational intervention gives the end user a lower whole life cost over the life of an asset.

As well as technology supply, both companies will provide relevant training and support where necessary.

Audun Lodemel, CEO of Biowater Technology commented:

“We are looking forward to working with Bluewater Bio in what is undoubtedly a mutually beneficial alliance between two companies that share the same vision and values. The combination of Bluewater’s high rate media filter with our own low footprint, cost effective biofilm technologies, such as the next generation Continuous Flow Intermittent Cleaning MBBR (CFIC®), allows us to address an even wider segment of the market – both municipal and industrial. Likewise, Bluewater Bio is well placed to benefit from the utilisation of our technologies to their global network. Customers will benefit from the combined solution with lower investment and operation costs.”

Bluewater Bio looks to consolidate global market position

Daniel Ishag, Founder and CEO of Bluewater Bio International added:

“We view Biowater as an important strategic partner going forward, as we look to consolidate our market position globally whilst opening up the new opportunities that Biowater’s technology portfolio affords us. We have seen interest in our FilterClear technology grow exponentially over the past few months, in response to compelling performance data from tertiary treatment installations at Anglian Water and – in combination with Biowater’s biofilm processes – at Nirlon in India.

“Just as Biowater gain access to our technology and distribution, we are able to utilise their high performance biofilm technologies. To continue building our leading, stand-alone technology platform, Bluewater Bio must expand our portfolio with innovative, small footprint, low energy technologies that complement our existing products.”

The agreement follows recent launch events at Tubli sewage treatment works in Bahrain, where Bluewater Bio’s HYBACS upgrade received critical acclaim from clients, politicians and future partners alike.

With both landmark developments under the firm’s belt by early February, Daniel Ishag said he was confident of the year ahead.

Founded in 2007 to develop HYBACS®, a patented ‘HYBrid ACtivated Sludge’ process, used by Severn Trent Water’s Ashbourne sewage treatment works in the UK, Bluewater has consistently pursued a strategy of organic and acquisitive growth. The firm combines its in-house R&D expertise with a highly entrepreneurial business approach  - as well as developing its own innovations, it also actively looks to adjacent markets for complementary IP, licence opportunities and partnerships.